- ·Macitentan API|Macitentan intermediates
- ·Baricitinib API|Baricitinib intermediates
- ·Apixaban API|Apixaban intermediates
- ·Cabozantinib API | Cabozantinib Intermediates
- ·Methotrexate APi|Methotrexate
- ·Pimavanserin API|Pimavanserin tartrate intermediates
- ·Brexpiprazole API|Brexpiprazole intermediates
- ·API|50508-60-6,50509-09-6
- ·Lurasidone API|Lurasidone intermediates
- ·Dapagliflozin API| Dapagliflozin Intermediate
Dapagliflozin
CAS:461432-26-8;960404-48-2MW:C21H25ClO6
Dapagliflozin(BMS512148) is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) is in development for the treatment of type 2 diabetes mellitus (T2DM).
Product Name:5-bromo-2-chloro-4'-ethoxydiphenylmethane
CAS:461432-23-5
MF: C15H14BrClO
MW:325.62806
Purity:99%
1-chloro-2-[(4-ethoxyphenyl)methyl]-4-iodo-Benzene
Other name: Benzene, 1-chloro-2-[(4-ethoxyphenyl)methyl]-4-iodo-; 1-Chloro-2-(4-Ethoxybenzyl)-4-Iodobenzene; 4-(5-Iodo-2-chlorobenzyl)phenyl ethyl ether
CAS: 1103738-29-9
MF: C15H14ClIO
MW: 372.6330
Purity:98.5%
Appearance:white powder
Import
Friendly link